In the present study, we also showed that HCC patients with high plasma IL-6 levels had higher AFP and DCP levels and a higher ratio of macrovascular invasion than those with low IL-6 levels (Table 3), suggesting a positive association between circulating IL-6 levels and HCC disease progression. The gene discussed is ACE; the disease is hepatocellular carcinoma.